uz
Feedback
Pharmatalks

Pharmatalks

Kanalga Telegram’da o‘tish

International Channel🎉 @Pharmatalks Chat group ✔️ @Pharmatalks_group Ads تبلیغات🔝 @Pharmatalkads Pharmacopoeia 📚 @USP_2024

Ko'proq ko'rsatish

📈 Telegram kanali Pharmatalks analitikasi

Pharmatalks (@pharmatalks) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 18 046 obunachidan iborat bo'lib, Taʼlim toifasida 11 226-o'rinni va AQSH mintaqasida 2 176-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 18 046 obunachiga ega bo‘ldi.

10 Iyun, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni -80 ga, so‘nggi 24 soatda esa -6 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 15.43% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 4.64% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 2 785 marta ko‘riladi; birinchi sutkada odatda 838 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 6 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent validation, pharma, pharmatalk, qualification, iso kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
International Channel🎉 @Pharmatalks Chat group ✔️ @Pharmatalks_group Ads تبلیغات🔝 @Pharmatalkads Pharmacopoeia 📚 @USP_2024

Yuqori yangilanish chastotasi (oxirgi ma’lumot 11 Iyun, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Taʼlim toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

18 046
Obunachilar
-624 soatlar
-117 kunlar
-8030 kunlar
Postlar arxiv
⚠️ Risk Management in the Pharmaceutical Industry In pharma, risk management helps teams protect patients, ensure quality, an
⚠️ Risk Management in the Pharmaceutical Industry In pharma, risk management helps teams protect patients, ensure quality, and maintain compliance. It also supports better decisions before small issues become major problems. Key risk areas include: ✅ Quality risk ✅ Operational risk ✅ Compliance risk ✅ Supply chain risk ✅ Safety risk ✅ Data integrity risk ✅ Equipment and process risk Common risk management tools include: 🔹 FMEA 🔹 HAZOP 🔹 Root Cause Analysis 🔹 Risk Matrix 🔹 Pareto Analysis 🔹 Checklists and SOPs Strong risk management helps pharma teams: ✅ Identify risks early ✅ Prioritize high-impact issues ✅ Reduce deviations and errors ✅ Improve CAPA effectiveness ✅ Strengthen GMP compliance ✅ Support patient safety Risk management is not just a document. It is a proactive mindset for safer products and stronger quality systems. Want to build stronger GMP risk management skills? 👉 Explore Pharmuni’s GMP Risk Management Principles course: https://pharmuni.com/courses/18/gmp-risk-management-principles

Where Are the Best Biotech and Pharmaceutical Jobs in the USA? 🇺🇸💊 📍 Top States for Biotech and Pharma Careers: ✅ Califor
Where Are the Best Biotech and Pharmaceutical Jobs in the USA? 🇺🇸💊 📍 Top States for Biotech and Pharma Careers: ✅ California – Strong biotech hubs, innovation, and research opportunities. ✅ Massachusetts – Known for biotech startups, R&D, and scientific innovation. ✅ New Jersey – Home to major pharmaceutical headquarters and regulatory roles. ✅ North Carolina – Growing opportunities in bioprocessing and manufacturing. ✅ Pennsylvania – Expanding biotech, production, and quality career options. ✅ Texas – Rising demand in clinical research and life sciences manufacturing. Whether you are starting your career or seeking your next position, focus on the right location, build relevant skills, and explore opportunities consistently. 🚀 Ready to take the next step in your pharmaceutical career? Explore pharma job opportunities on Pharmuni: https://l1nq.com/eevf8pq

🔐 Key Requirements of 21 CFR Part 11 Training In regulated pharma environments, electronic records and electronic signatures
🔐 Key Requirements of 21 CFR Part 11 Training In regulated pharma environments, electronic records and electronic signatures must be controlled, traceable, and reliable. Teams should understand: ✅ When 21 CFR Part 11 applies ✅ Why computerized systems need validation ✅ How audit trails support traceability ✅ Why access control protects data integrity ✅ How electronic signatures must be managed ✅ Why SOPs and training are essential ✅ How record integrity supports inspection readiness 21 CFR Part 11 is not only an IT topic. It connects quality, compliance, validation, documentation, and patient safety. Want to build stronger knowledge in computerized system compliance? 👉 Explore Pharmuni’s Introduction to Computer Systems Validation (CSV) course: https://shorturl.at/EyAuD

🚨 FDA Finalizes 3-Part ICH M11 Digital Protocol Standard . Key points include: ✅ A structured clinical protocol guideline ✅
🚨 FDA Finalizes 3-Part ICH M11 Digital Protocol Standard . Key points include: ✅ A structured clinical protocol guideline ✅ A standardized protocol template ✅ A technical specification for digital exchange ✅ Better consistency across trial submissions ✅ Improved clarity for sponsors and regulators ✅ Less ambiguity in protocol content ✅ Stronger support for global clinical trial efficiency 📌 Read the full news here: https://sl1nk.com/kd7xmys

🚨 FDA Finalizes 3-Part ICH M11 Digital Protocol Standard . Key points include: ✅ A structured clinical protocol guideline ✅ A standardized protocol template ✅ A technical specification for digital exchange ✅ Better consistency across trial submissions ✅ Improved clarity for sponsors and regulators ✅ Less ambiguity in protocol content ✅ Stronger support for global clinical trial efficiency 📌 Read the full news here: https://sl1nk.com/kd7xmys

⚙️ Common Pitfalls in IQ, OQ, and PQ . ✅ Incomplete installation records ✅ Missing utility or component checks ✅ Poorly defin
⚙️ Common Pitfalls in IQ, OQ, and PQ . ✅ Incomplete installation records ✅ Missing utility or component checks ✅ Poorly defined test parameters ✅ Untrained personnel running tests ✅ Weak acceptance criteria ✅ Not simulating real operating conditions ✅ Insufficient run data or sampling ✅ Delayed deviation documentation ✅ Poor traceability of qualification records How can teams avoid these issues? 🔹 Use approved protocols and checklists 🔹 Define acceptance criteria clearly 🔹 Train staff before execution 🔹 Document deviations immediately 🔹 Review results carefully 🔹 Maintain traceable GMP records Want to strengthen your IQ, OQ, and PQ execution skills? 👉 Explore Pharmuni’s Performing Phase of GMP Equipment Qualification course: https://pharmuni.com/courses/39/performing-phase-of-gmp-equipment-qualification

⚙️ Common Pitfalls in IQ, OQ, and PQ . ✅ Incomplete installation records ✅ Missing utility or component checks ✅ Poorly defined test parameters ✅ Untrained personnel running tests ✅ Weak acceptance criteria ✅ Not simulating real operating conditions ✅ Insufficient run data or sampling ✅ Delayed deviation documentation ✅ Poor traceability of qualification records How can teams avoid these issues? 🔹 Use approved protocols and checklists 🔹 Define acceptance criteria clearly 🔹 Train staff before execution 🔹 Document deviations immediately 🔹 Review results carefully 🔹 Maintain traceable GMP records Want to strengthen your IQ, OQ, and PQ execution skills? 👉 Explore Pharmuni’s Performing Phase of GMP Equipment Qualification course: https://pharmuni.com/courses/39/performing-phase-of-gmp-equipment-qualification

GLP vs GMP Presentation

British Pharmacopoeia Comparison with other USP , EU

Top Pharma Regulatory Bodies 50 MOST ASKED QUESTIONS & ANSWERS

Repost from Pharmatalks
Understanding ICH Quality Guidelines: A Quick Overview 🌍⚙️ The International Council for Harmonisation (ICH) Quality Guidelines are essential for ensuring the safety, efficacy, and quality of pharmaceuticals worldwide. Here's a quick summary to keep you informed: Watch NOW PHARMATALKS FULL Podcast HERE https://youtu.be/GhnWNgXbigs?si=MMVwtlBogSMTLAFo 1. Q1 Series (Stability Testing) 🧪     Focuses on stability testing protocols to determine shelf life and storage conditions. 2. Q2(R1) (Analytical Validation) 🔬     Provides guidance on validating analytical procedures to ensure accuracy and reliability. 3. Q3A/B (Impurities) 💊     Addresses impurities in drug substances and products, emphasizing control strategies. 4. Q4B (Pharmacopoeial Harmonization) 📚     Facilitates harmonization of monographs across different pharmacopoeias. 5. Q5 Series (Quality of Biotechnological/ Biological Products) 🧬     Covers quality considerations specific to biotech and biological products.

ICH M11 2026 Update

Repost from Pharmatalks
SOP for Self Inspection Procedure 👇👇👇 Join the #Pharmatalks community and gain access to over 2,000 documents on the #pharmaceuticalIndustry! 📚💊 Don't miss out, click the link below to join now! 👇👇👇👇👇👇👇 https://t.me/addlist/YMYs20TiWdY1MTY0

Repost from Pharmatalks
Summary of ICH Quality Guidelines 👇👇👇 Join the #Pharmatalks community and gain access to over 2,000 documents on the #phar
Summary of ICH Quality Guidelines 👇👇👇 Join the #Pharmatalks community and gain access to over 2,000 documents on the #pharmaceuticalIndustry! 📚💊 Don't miss out, click the link below to join now! 👇👇👇👇👇👇👇 https://t.me/addlist/YMYs20TiWdY1MTY0

Repost from Pharmatalks
Understanding ICH Quality Guidelines: A Quick Overview 🌍⚙️ The International Council for Harmonisation (ICH) Quality Guidelines are essential for ensuring the safety, efficacy, and quality of pharmaceuticals worldwide. Here's a quick summary to keep you informed: Watch NOW PHARMATALKS FULL Podcast HERE https://youtu.be/GhnWNgXbigs?si=MMVwtlBogSMTLAFo 1. Q1 Series (Stability Testing) 🧪     Focuses on stability testing protocols to determine shelf life and storage conditions. 2. Q2(R1) (Analytical Validation) 🔬     Provides guidance on validating analytical procedures to ensure accuracy and reliability. 3. Q3A/B (Impurities) 💊     Addresses impurities in drug substances and products, emphasizing control strategies. 4. Q4B (Pharmacopoeial Harmonization) 📚     Facilitates harmonization of monographs across different pharmacopoeias. 5. Q5 Series (Quality of Biotechnological/ Biological Products) 🧬     Covers quality considerations specific to biotech and biological products.

Repost from Pharmatalks
Understanding ICH Quality Guidelines: A Quick Overview 🌍⚙️ The International Council for Harmonisation (ICH) Quality Guidelines are essential for ensuring the safety, efficacy, and quality of pharmaceuticals worldwide. Here's a quick summary to keep you informed: Watch NOW PHARMATALKS FULL Podcast HERE https://youtu.be/GhnWNgXbigs?si=MMVwtlBogSMTLAFo 1. Q1 Series (Stability Testing) 🧪     Focuses on stability testing protocols to determine shelf life and storage conditions. 2. Q2(R1) (Analytical Validation) 🔬     Provides guidance on validating analytical procedures to ensure accuracy and reliability. 3. Q3A/B (Impurities) 💊     Addresses impurities in drug substances and products, emphasizing control strategies. 4. Q4B (Pharmacopoeial Harmonization) 📚     Facilitates harmonization of monographs across different pharmacopoeias. 5. Q5 Series (Quality of Biotechnological/ Biological Products) 🧬     Covers quality considerations specific to biotech and biological products.

🔟 Top 10 Pillars of Chromatography 📽️ Watch the Full Video Now 👉https://www.youtube.com/watch?v=OdjjLjUcW8I ⚗️ Stationary
🔟 Top 10 Pillars of Chromatography 📽️ Watch the Full Video Now 👉https://www.youtube.com/watch?v=OdjjLjUcW8I ⚗️ Stationary Phase 💧 Mobile Phase 🧪 Sample Preparation ⏱️ Flow Rate Control 🌡️ Temperature Control 🎯 Detector Selection 📊 System Suitability 🧠 Method Development 🛡️ Data Integrity & Compliance 🔧 Maintenance & Calibration

🔟 Top 10 Pillars of Chromatography ⚗️ Stationary Phase 💧 Mobile Phase 🧪 Sample Preparation ⏱️ Flow Rate Control 🌡️ Temperature Control 🎯 Detector Selection 📊 System Suitability 🧠 Method Development 🛡️ Data Integrity & Compliance 🔧 Maintenance & Calibration

🔬 Key Aspects of Bioburden Testing: 📺 👉 WATCH OUR COMPLETE GUIDE TO BIOBURDEN TESTING! 1. Purpose: Determines the microbia
🔬 Key Aspects of Bioburden Testing: 📺 👉 WATCH OUR COMPLETE GUIDE TO BIOBURDEN TESTING! 1. Purpose: Determines the microbial load before terminal sterilization 2. When Performed: On raw materials, in-process samples, and finished products 3. Methods Used: Membrane filtration, pour plate, spread plate, and most probable number (MPN) 4. Microorganisms Detected: Bacteria, yeast, mold, and sometimes specific indicator organisms 5. Regulatory Requirements: Mandated by FDA, EMA, and other global health authorities 6. Critical Limits: Varies by product type and intended use 7. Validation: Methods must be validated for each product type 8. Environmental Monitoring: Linked to cleanroom classification and monitoring 9. Trend Analysis: Data used for continuous improvement 10. Sterility Assurance: Directly impacts sterilization validation (D-value calculations)

⏱️ Steps for Handling OOS Results ⛨ Phase 1: Laboratory Investigation ✔ Immediate actions ✔ Analyst’s self-check ✔ Instrument
⏱️ Steps for Handling OOS Results ⛨ Phase 1: Laboratory Investigation ✔ Immediate actions ✔ Analyst’s self-check ✔ Instrument review ✔ Sample preparation verification ✔ Chromatograms review (integration errors, system suitability) ⛨ Phase 1 Outcome Invalid result → assign root cause, re-test allowed. No assignable cause → move to Full-Scale Investigation. ⛨ Phase 2: Full-Scale Investigation (QA + Production) ✔ Review of manufacturing batch records ✔ Review of deviations, environment, equipment ✔ Evaluation of analyst training ✔ Hypothesis testing (additional testing if justified) ✔ Impact assessment on other batches